文献速递乳腺US乳腺X线

韩国40至49岁乳腺癌患者按检测方式划分的生存率:筛查超声与乳腺X线摄影比较

Survival Rates of Breast Cancer Patients Aged 40 to 49 Years according to Detection Modality in Korea: Screening Ultrasound versus Mammography.
PubMed 文献 · Korean J Radiol · 2020-08-28

该单机构回顾性研究纳入2003至2008年接受乳腺癌手术的240例40至49岁韩国女性,比较补充筛查超声(43例)与筛查乳腺X线摄影(197例)检出乳腺癌的生存率。超声组无病生存率更优(p=0.016),多变量分析显示超声组复发风险更低(HR 0.097,95%CI 0.001-0.705),但总生存率两组差异未达统计学显著(p=0.058)。

要点

  • 超声检出组无病生存率优于乳腺X线检出组(p=0.016),但总生存率差异未达统计学显著(p=0.058)。
  • 多变量分析中超声检出组复发风险更低(HR 0.097,95%CI 0.001-0.705)。
  • 93.3%为致密乳腺,全部19例复发和16例死亡均发生在乳腺X线检出组。

核心结论

  • 韩国40至49岁女性中,超声检出乳腺癌者的无病生存率优于乳腺X线检出者,但总生存率无统计学显著差异。

研究设计与样本

  • 单机构回顾性研究,纳入2003至2008年接受乳腺癌手术的240例40至49岁乳腺癌患者(平均年龄45.1±2.8岁)。
  • 按检测方式分为补充筛查超声组43例和筛查乳腺X线摄影组197例,平均随访7.4年,93.3%为致密乳腺。
  • 采用log-rank检验比较两组无病生存率和总生存率,多变量Cox回归分析确定与无病生存率和总生存率相关的独立变量。

诊断标准与关键数值

  • 超声组与乳腺X线组肿瘤分期无差异,但超声组更常接受保乳手术和放疗。
  • 超声组无病生存率优于乳腺X线组(p=0.016),总生存率两组差异未达统计学显著(p=0.058)。
  • 多变量分析中超声组复发风险低于乳腺X线组(HR 0.097,95%CI 0.001-0.705)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to compare the survival rates of Korean females aged 40 to 49 years with breast cancer detected by supplemental screening ultrasound (US) or screening mammography alone.

MATERIALS AND METHODS: This single-institution retrospective study included 240 patients with breast cancer (mean age, 45.1 ± 2.8 years) detected by US or mammography who had undergone breast surgery between 2003 and 2008. Medical records were reviewed for clinicopathologic characteristics and detection methods. Disease-free survival (DFS) and overall survival (OS) were compared between patients with breast cancer in the US and mammography groups using the log-rank test. Multivariable cox regression analysis was used to identify independent variables associated with DFS and OS.

RESULTS: Among the 240 cases of breast cancer, 43 were detected by supplemental screening US and 197 by screening mammography (mean follow-up: 7.4 years, 93.3% with dense breasts). There were 19 recurrences and 16 deaths, all occurring in the mammography group. While the US group did not differ from the mammography group in tumor stage, the patients in this group were more likely to undergo breast-conserving surgery and radiation therapy than the mammography group. The US group also showed better DFS (p = 0.016); however, OS did not differ between the two groups (p = 0.058). In the multivariable analysis, the US group showed a lower risk of recurrence (hazard ratio, 0.097; 95% confidence interval, 0.001-0.705) compared to the mammography group.

CONCLUSION: Our study found that Korean females aged 40-49 years with US-detected breast cancer showed better DFS than those with mammography-detected breast cancer. However, there were no statistically significant differences in OS.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Won SY, Park HS, Kim EK, et al. Survival Rates of Breast Cancer Patients Aged 40 to 49 Years according to Detection Modality in Korea: Screening Ultrasound versus Mammography. Korean J Radiol. 2020. PMID: 32901456. doi:10.3348/kjr.2019.0588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。